Aug
1
Apr
18
New FDA Guidance for Long-standing Deferral; HIV Changes
The Food and Drug Administration issued new guidance on blood donations, removing some long-standing deferrals. In addition to this, the FDA is also considering moving towards an individualized risk-based approach when deciding donor eligibility. These changes are related to HIV medications and those at risk for contracting HIV.
This is a test of the sitewide banner capability. In the case of an emergency, site visitors would be able to visit the news page for addition information.
Important information on storage and handling of JYNNEOS vaccine
On September 24, 2019, the U.S. Food and Drug Administration approved the first live, non-replicating vaccine for prevention of smallpox and monkeypox disease in adults 18 years of age and older determined to be at high risk for smallpox or monkeypox infection.
While there is currently no vaccine available from the manufacturer for use, the Department of Defense and other government partners are engaged in robust discussions regarding future deployment of this vaccine within the military.
Further information will be provided once available.
You will find below all of the resources you will need about the Jynneos smallpox/mpox vaccine. More will be added as they are published or released.
The appearance of hyperlinks does not constitute endorsement by the Department of Defense of non-U.S. Government sites or the information, products, or services contained therein. Although the Defense Health Agency may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website.